Variant report
Variant | nsv965669 |
---|---|
Chromosome Location | chr6:161410268-161411309 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:61)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CUX1 | chr6:161410876-161410997 | K562 | blood: | n/a | n/a |
2 | IRF1 | chr6:161411201-161414520 | K562 | blood: | n/a | chr6:161412699-161412713 chr6:161412677-161412691 chr6:161413152-161413166 |
3 | KAP1 | chr6:161411200-161412225 | K562 | blood: | n/a | n/a |
4 | KAP1 | chr6:161410421-161410896 | K562 | blood: | n/a | n/a |
5 | MAX | chr6:161411067-161411426 | K562 | blood: | n/a | n/a |
6 | POLR2A | chr6:161410735-161411360 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | POLR2A | chr6:161410057-161414247 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr6:161410637-161414109 | IMR90 | lung: | n/a | n/a |
9 | RFX5 | chr6:161411122-161411680 | K562 | blood: | n/a | n/a |
10 | STAT3 | chr6:161410265-161410427 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161411013-161411063 | A549 | lung: | n/a |
2 | chr6:161411013-161411063 | MCF10A-Er-Src | breast: | n/a |
3 | chr6:161411013-161411063 | SKMC | muscle: | n/a |
4 | chr6:161411013-161411063 | GM12891 | blood: | n/a |
5 | chr6:161411013-161411063 | HMEC | breast: | n/a |
6 | chr6:161411013-161411063 | AG09309 | skin: | n/a |
7 | chr6:161411013-161411063 | HCT-116 | colon: | n/a |
8 | chr6:161411013-161411063 | K562 | blood: | n/a |
9 | chr6:161411013-161411063 | NHDF-neo | bronchial: | n/a |
10 | chr6:161411013-161411063 | NHBE | bronchial: | n/a |
11 | chr6:161411013-161411063 | SK-N-SH | brain: | n/a |
12 | chr6:161411013-161411063 | Caco-2 | colon: | n/a |
13 | chr6:161411013-161411063 | HRCEpiC | kidney: | n/a |
14 | chr6:161411013-161411063 | ProgFib | skin: | n/a |
15 | chr6:161411013-161411063 | HEK293 | kidney: | embryo |
16 | chr6:161411013-161411063 | AoSMC | blood vessel: | n/a |
17 | chr6:161411013-161411063 | LNCaP | prostate: | n/a |
18 | chr6:161411013-161411063 | Jurkat | blood: | n/a |
19 | chr6:161411013-161411063 | HIPEpiC | eye: | n/a |
20 | chr6:161411013-161411063 | HPAEpiC | pulmonary alveolar: | n/a |
21 | chr6:161411013-161411063 | NT2-D1 | testis: | n/a |
22 | chr6:161411013-161411063 | SK-N-SH_RA | brain: | n/a |
23 | chr6:161411013-161411063 | HAEpiC | amniotic membrane: | n/a |
24 | chr6:161411013-161411063 | HEEpiC | esophagus: | n/a |
25 | chr6:161411013-161411063 | GM12878 | blood: | n/a |
26 | chr6:161411013-161411063 | BE2_C | brain: | n/a |
27 | chr6:161411013-161411063 | HepG2 | liver: | n/a |
28 | chr6:161411013-161411063 | GM12892 | blood: | n/a |
29 | chr6:161411013-161411063 | GM19239 | blood: | n/a |
30 | chr6:161411013-161411063 | T-47D | breast: | n/a |
31 | chr6:161411013-161411063 | IMR90 | lung: | fetal |
32 | chr6:161411013-161411063 | PANC-1 | pancreas: | n/a |
33 | chr6:161411013-161411063 | BJ | skin: | n/a |
34 | chr6:161411013-161411063 | ovcar-3 | ovarian: | n/a |
35 | chr6:161411013-161411063 | HNPCEpiC | eye: | n/a |
36 | chr6:161411013-161411063 | AG04449 | skin: | fetal |
37 | chr6:161411013-161411063 | ECC-1 | luminal epithelium: | n/a |
38 | chr6:161411013-161411063 | AG10803 | skin: | n/a |
39 | chr6:161411013-161411063 | H1-hESC | embryonic stem cell: | embryo |
40 | chr6:161411013-161411063 | CMK | blood: | n/a |
41 | chr6:161411013-161411063 | SAEC | small airway: | n/a |
42 | chr6:161411013-161411063 | HRE | kidney: | n/a |
43 | chr6:161411013-161411063 | RPTEC | kidney: | n/a |
44 | chr6:161411013-161411063 | NB4 | blood: | n/a |
45 | chr6:161411013-161411063 | SK-N-MC | brain: | n/a |
46 | chr6:161411013-161411063 | AG09319 | gingival: | n/a |
47 | chr6:161411013-161411063 | HCM | heart: | n/a |
48 | chr6:161411013-161411063 | HL-60 | blood: | n/a |
49 | chr6:161411013-161411063 | AG04450 | lung: | fetal |
50 | chr6:161411013-161411063 | U87 | brain: | n/a |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161381731..161384627-chr6:161408472..161410807,2 | K562 | blood: | |
2 | chr6:161409929..161412719-chr6:161465318..161467396,2 | K562 | blood: | |
3 | chr6:161349966..161354183-chr6:161410810..161413824,4 | MCF-7 | breast: | |
4 | chr6:161407945..161411607-chr6:161664296..161666241,4 | K562 | blood: | |
5 | chr6:161408989..161411018-chr6:161411162..161414602,4 | MCF-7 | breast: | |
6 | chr6:161409514..161411733-chr6:161434300..161435929,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MAP3K4 | TF binding region |
MAP3K4 | CpG island |
ENSG00000272841 | chromatin interactions |
ENSG00000231863 | chromatin interactions |
ENSG00000085511 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553261695 | chr6:161410268-161410269 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs568303999 | chr6:161410269-161410270 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs189030816 | chr6:161410280-161410281 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs9458075 | chr6:161410327-161410328 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs182065522 | chr6:161410539-161410540 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs377190116 | chr6:161410563-161410564 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs62438069 | chr6:161410587-161410588 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs374150236 | chr6:161410589-161410590 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs80170790 | chr6:161410590-161410591 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs398003226 | chr6:161410601-161410602 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs150302748 | chr6:161410602-161410603 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs77461035 | chr6:161410603-161410604 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs35671722 | chr6:161410693-161410694 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs146539359 | chr6:161410796-161410797 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs141236215 | chr6:161410797-161410798 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs145046707 | chr6:161410840-161410841 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs186363135 | chr6:161410853-161410854 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs191151856 | chr6:161410871-161410872 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs610538 | chr6:161410911-161410912 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs610638 | chr6:161410978-161410979 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs546221225 | chr6:161411014-161411015 | Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs180729969 | chr6:161411056-161411057 | Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs186578778 | chr6:161411068-161411069 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs568361320 | chr6:161411077-161411078 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs191029582 | chr6:161411087-161411088 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs561179461 | chr6:161411095-161411096 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs138834838 | chr6:161411097-161411098 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs547086520 | chr6:161411150-161411151 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs35824415 | chr6:161411155-161411156 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs372776266 | chr6:161411214-161411215 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs149085015 | chr6:161411228-161411229 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs539180904 | chr6:161411278-161411279 | Active TSS Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161408200-161410800 | Weak transcription | K562 | blood |
2 | chr6:161408200-161411800 | Weak transcription | Fetal Muscle Leg | muscle |
3 | chr6:161409400-161411400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr6:161409600-161411000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr6:161409800-161410800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr6:161410800-161411200 | Enhancers | K562 | blood |
7 | chr6:161410800-161411600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr6:161411000-161411600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr6:161411200-161411400 | Flanking Active TSS | K562 | blood |
10 | chr6:161411200-161411600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr6:161411200-161414000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:161411200-161414600 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |